CXCL16, which recruits CXCR6 expressing Th1 and CD8+ effector T cells, is upregulated by both mouse and human breast cancer cells; CXCR6 deficient mice experienced impaired tumor regression and decreased CD8+ T cell infiltration after irradiation (57, 58). The gene discussed is CD8A; the disease is neoplasm.